Truvada

Development of Ingestible Biosensors to Enhance PrEP Adherence in Substance Users (PrEPSteps)

Uptake and Adherence to Daily Oral PrEP as a Primary Prevention Strategy for Young African Women: A Vanguard Study

Biobehavioral Interventions for HIV-negative, Stimulant Using Men Who Have Sex With Men

REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment

PrEPsmart 2-1-1 Pilot

Effects of the Anti-HIV Pill Truvada on Gene Transcription in the Gastrointestinal Tract of HIV-uninfected Individuals

Dual Therapy With Boosted Darunavir + Dolutegravir

PrEPared-RN, CAN Nurse-Led Management of High-risk Patients for Pre-Exposure Prophylaxis (PrEP)

Acceptability, Safety, and Use of Daily Truvada Pre-Exposure Prophylaxis in Adolescents

Providing PrEP, Hepatitis C Treatment, and MOUD Through Telemedicine at Greensboro SSP

ADVANCE Study of DTG + TAF + FTC vs DTG + TDF + FTC and EFV + TDF+FTC in First-line Antiretroviral Therapy

Dolutegravir in Reservoirs

Feasibility and Acceptability of Digital Pills to Monitor PrEP Adherence in MSM With Substance Use

Immediate or Deferred Pre-exposure Prophylaxis for HIV Prevention: Safe Options for Pregnant and Lactating Women

The Prevention Options for Women Evaluation Research (POWER) Cohort

The Role of Home Packs of HIV PEPSE in High Risk Individuals

Tenofovir Adherence to Rapidly Guide and Evaluate PrEP and HIV Therapy

The Maraviroc Darunavir/Ritonavir Once Daily Pharmacokinetic Study

Body Compartment PK for New HIV Pre-exposure Prophylaxis Modalities

A Dose-Ranging Study to Compare Doravirine (MK-1439) Plus TRUVADA® Versus Efavirenz Plus TRUVADA® in Human Immunodeficiency Virus (HIV)-1 Infected Participants (MK-1439-007)